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ANOVA, analysis of variance 
C.A.S.T., computer assisted stereological toolbox 
CE, coefficient of error 
CET, chronic ethanol treatment 
CV, coefficient of variation 
DA, dopamine 
GABA, gamma-aminobutyric acid 
i.c.v., intracerebroventricular 
NAc, nucleus accumbens 
NGF, nerve growth factor 
NPY, neuropeptide Y 
NPY-ir, neuropeptide Y immunoreactive 
PB, phosphate buffer 
PBS, phosphate-buffered saline 
SD, standard deviation 
TrkA, tyrosine kinase receptor A 







The nucleus accumbens (NAc) is known for its role in mediating the reinforcing effects of 
drugs of abuse. Neuropeptide Y (NPY) displays a pivotal role in anxiety, stress, rewarding 
processes and drug abuse. It may influence ethanol intake by regulating basal levels of 
anxiety and by modulating the sedative effects of ethanol and/or its rewarding properties. 
Nerve growth factor (NGF), whose levels are decreased during chronic ethanol treatment 
(CET) and withdrawal (W), plays a key role in NPY expression. We examined the effects of 
CET, W and NGF on the total number of NPY-immunoreactive (NPY-ir) neurons in the 
NAc. Rats were assigned to adult control, CET and W groups and to an old CET group. 
Stereological methods and NPY immunostained material were used to estimate the total 
number and the somatic volume of NPY-ir neurons. We found an increase in NPY expression 
in adult CET rats. Furthermore, we found that W reduces the expression of NPY to control 
levels. On the contrary, in old CET rats the expression of NPY was reduced to about 48% of 
the levels in adult CET animals. It was also found that NGF treatment of W rats significantly 
increased the expression of NPY in the NAc relative to non-treated W and control rats. These 
results demonstrate that age interferes with the effects of CET in the expression of NPY in 
the NAc and that NGF regulates the phenotype of NPY-ir neurons. This study might help to 





KEY WORDS  








The  nucleus accumbens (NAc) is a central component of the limbic system (Goto and Grace, 
2008) and a major terminal area of the dopaminergic mesocorticolimbic system, known to 
play a critical role in the motivational and addictive properties of drugs of abuse (Ochoa et 
al., 1990; Kelley et al., 1997). It is immunohistochemically divided into three subterritories: 
in the caudal three fourths it is composed by a central “core” and a surrounding “shell” and in 
the rostral one-fourth, where the core and shell cannot be identified, by the “rostral pole” 
(Zahm and Heimer, 1993). It is one of the brain regions with highest concentrations of 
neuropeptide Y (NPY; Salin et al., 1990), a 36 amino acid peptide that has remained 
extremely well conserved throughout vertebrate evolution (Barreiro-Iglesias et al., 2010) and 
is abundantly expressed in the central nervous system, most notably in the limbic structures 
(Heilig, 2004). NPY displays a pivotal role in anxiety, stress, rewarding processes, 
neurobiological responses to ethanol and drug abuse (Heilig et al., 1992; Pandey et al., 2003; 
Cippitelli et al., 2010).  
Nerve growth factor (NGF) is a member of the neurotrophin family. Neurotrophins 
are a family of growth factors that critically regulate many aspects of neuronal development 
and function, exerting their effects via two types of receptors, the tyrosine kinase receptor 
(TrK) and the p75 neurotrophin receptor (Huang and Reichardt, 2003, Hempstead, 2006, 
Zampieri and Chao, 2006). There is growing evidence that neurotrophins regulate the gene 
expression and the protein levels of neuropeptides under several conditions (Lindsay and 




to NGF, it has been recently shown that it can restore the activity of NPYergic neurons in the 
NAc (unpublished results) and somatosensory cortex (Cardoso et al., 2006) of aged rats.  
In rodents, chronic ethanol treatment (CET) and withdrawal (W) alter NPY levels in 
several brain areas, such as the arcuate nucleus and the cingulate gyrus (Clark et al., 1998; 
Ehlers et al., 1998; Roy and Pandey, 2002). Previous studies have also shown that, in adult 
rodents, CET reduces NGF and TrkA levels in several regions of the brain (Aloe and Tirassa, 
1992; Aloe et al., 1993; Heaton et al., 2003). On the grounds of these data, we have 
hypothesized that CET and W might alter NPY expression in the NAc through a mechanism 
mediated, in part at least, by changes in NGF levels. To test this possibility, we have 
examined the effects of CET and W on the total number of NPY–immunoreactive (NPY-ir) 
neurons in the NAc, and investigated if the administration of NGF interferes with the 
expression of NPY by its neurons. Because the levels of NGF and its mRNA have been 
reported to be reduced in several regions of the aged brain (Terry et al., 2011), we have 
additionally investigated whether there are age-dependent effects of CET on the NPY 





Animals and treatments 
A total of 25 Wistar male rats were used. Food and water were available ad libitum until rats 
were 2-months old. Then, rats were assigned to control (n = 5), adult CET (n = 15) and old 
CET (n = 5) groups. Adult CET rats received a 20% (V/V) aqueous ethanol solution as their 
only available liquid source for 6 months, starting at 2 months of age. At 8 months of age, 10 




Five of these rats (W group) received no further treatment whereas the remaining (n = 5; 
W+NGF group) were submitted to surgery for implantation of osmotic minipumps that 
allowed intracerebroventricular (i.c.v.) delivery of NGF. Because there is evidence that this 
surgical procedure does not interfere with the central NPYergic system (Cardoso et al., 2006), 
vehicle-treated rats were not included in this study. The old group of CET rats was treated as 
the adult one, but from 18 to 24 months of age. 
The experiments were performed in accordance with European Communities Council 
Directives of 24 November 1996 (86/609/EEC) and Portuguese Act no. 129/92. All efforts 
were made to minimize the number of animals used and their discomfort and suffering. 
 
Surgical procedures and drug treatment 
For i.c.v. administration of NGF, rats were anesthetized by sequentially injecting, at intervals 
of 10 min, solutions in physiological saline of 0.25% promethazine (0.4 ml/kg body weight, 
subcutaneous; Fenergan, Laboratórios Vitória, Amadora, Portugal), followed by 2% xylazine 
(0.132 ml/kg body weight, intramuscular; Sigma – Aldrich, Madrid, Spain) and, finally, 10% 
ketamine (0.5ml/kg body weight, intramuscular; Imalgene 1000, Merial Portuguesa, Rio de 
Mouro, Portugal). Then, they were placed on a stereotaxic apparatus with bregma and lambda 
in the same horizontal plane. After a midline incision on the scalp, the calvaria was exposed. 
For i.c.v. delivery of NGF, permanent stainless steel cannulae (Alzet brain infusion kit) were 
stereotaxically placed in the right lateral ventricle at the following coordinates (Paxinos et al., 
1998): 1.1 mm posterior to the bregma, 1.7 mm lateral to the midline, and 4.0 mm below the 
surface of the skull. The cannulae were connected to Alzet osmotic minipumps (model 2002; 
Alza Corporation, Palo Alto, CA, USA) and filled with methylene blue (0.01%, Sigma – 
Aldrich, Madrid, Spain) via sterile coiled polyethylene tubing (PE-60; Intramedic, Becton 




(Vahlsing et al., 1989), and with NGF at the cannula end (150 µg diluted in 150 µl of 
vehicle). Osmotic minipumps were pre-tested to confirm their delivery rate, and implanted 
subcutaneously in the neck. In all operated rats, incisions on the skin of the scalp were closed 
with surgical stitches and treated with local antiseptic. After surgery, rats were individually 
housed and maintained in a warm place until waking up. Postoperative care consisted of 
subcutaneous injections of 0.9% saline (2 ml) to prevent dehydration and weight loss. Twelve 
days after the beginning of the i.c.v. infusions, the animals were killed and the total infusion 
volume calculated. The total infusion volume was 135.31 ± 27.31 µl of NGF per animal. 
 
Tissue preparation  
At the end of the experimental periods, animals were deeply anesthetized by intraperitoneal 
injection of a solution (3 ml/kg body weight) containing 1% sodium pentobarbital and 4% 
chloral hydrate in physiological saline. Then, they were perfused transcardially with 150 ml 
of 0.1 M phosphate buffer (PB; pH 7.6) for vascular rinse, followed by 250 ml of a fixative 
solution containing 4% paraformaldehyde in PB, at pH 7.6. The brains were removed from 
the skulls, coded, immersed for 1 h in the same fixative, and maintained overnight in a 
solution of 10% sucrose in PB, at 4 ºC. The brains were placed on a vibratome and serially 
sectioned in the coronal plane at 40 µm through the NAc. The sections were collected in 
phosphate-buffered saline (PBS). 
From the entire set of sections obtained from each brain, four series were formed by 
using a systematic, random sampling procedure. Specifically, the first section of each set was 
randomly selected, and the remaining were sampled, along the entire rostrocaudal extent of 
the NAc, at regular intervals of 160 µm, that is, by sampling 1 out of 4 sections. The first set 
thus formed was used for Nissl staining, whereas the other, composed of sections adjacent to 






Sections were mounted serially on gelatin-coated slides. After air-drying overnight at room 
temperature, they were stained with Cresyl Violet, dehydrated, and coverslipped with 
Histomount (National Diagnostics, Atlanta, GA, USA). The observations of these sections 
under light microscopy allowed to accurately establish the boundaries of the NAc in the 
immunostained sections (Fig. 1A). 
 
Immunostaining for NPY 
Sections were washed twice in PBS, treated with 3% H2O2 for 10 min to inactivate 
endogenous peroxidase, and incubated overnight at 4 ºC with the primary antiserum against 
NPY (Chemicon, Temecula, CA, USA; 1: 10,000 dilution in PBS). Biotinylated goat anti-
rabbit antibody (Vector Laboratories, Burlingame, CA, USA, 1 : 400 dilution in PBS) was 
used as the secondary antibody. Sections were then treated with avidin–biotin peroxidase 
complex (Vectastain Elite ABC kit, Vector Laboratories, Burlingame, CA, USA, 1 : 800 
dilution in PBS). In the last two steps, the incubation was carried out for at least 1 h at room 
temperature. Following treatment with peroxidase complex, sections were incubated for 10 
min in 0.05% diaminobenzidine (Sigma – Aldrich, Madrid, Spain) to which 0.01% H2O2 was 
added. Sections were rinsed with PBS for at least 15 min between each step. Tissue 
penetration was increased by the inclusion of 0.5% Triton X-100 in all immunoreactions and 
washes. All procedures were performed on a rocking table. 
Immunostained sections were mounted on gelatin-coated slides and air-dried. They 
were then dehydrated in a series of ethanol solutions (70%, 90%, 95% and 100%), cleared in 
xylol and coverslipped using Histomount (National Diagnostics, Atlanta, GA, USA). To 




the same time. The same procedure was followed for control sections, which were incubated 
without antiserum; no immunostaining was observed in these sections. 
 
Stereological analysis 
The optical fractionator method (West et al., 1991; Madeira et al., 1997) was used to estimate 
the total number of NPY-ir neurons on blind-coded slides. The boundaries of NAc were 
consistently defined on the basis of cell morphology (Fig. 1) and cytoarchitectonic criteria. 
The method for carrying out this delimitation was the systematic identification of a high cell 
density area around the anterior commissure, and located beneath the rostral caudate-putamen 
and above the olfactory tubercle. The cellular pattern of this area resembles that of the 
caudate-putamen and olfactory tubercle to such an extent that it is difficult to define the 
border between them. Likewise, the caudal parts of the nucleus merge without clear boundary 
into the bed nucleus of the stria terminalis. Conversely, the medial part of the NAc is 
separated from the septum-diagonal band complex by a distinct, arciform boundary, whereas 
rostrally and laterally it extends until the external capsule (Zahm and Brog, 1992). 
Cell counting was carried out using an Olympus C.A.S.T.-Grid system (Olympus DK 
A/S, Denmark) and a Hiedenhain MT-12 microcator (Heidenhain, Germany). All the 
estimations were performed at a final magnification of 2000x. All the sections previously 
immunostained for NPY and containing the NAc were used, which provided an average of 13 
sections per animal. In each section, fields of view were systematically sampled using a step 
size of 250 µm along the x and y axes; the disector used had a counting frame area of 8436 
µm2 at the tissue level and a fixed depth of 10 µm. Immunostaining of the perikaryal 
cytoplasm with a relatively unstained nucleus was the criterion used for the identification of 




NPY-ir cells was counted per nucleus. The mean coefficient of error (CE) of the estimates 
was 0.08.  
The mean somatic volume of NPY-ir neurons was estimated by applying the optical 
rotator method (Tandrup et al., 1997). Neurons used for measurements were selected by 
means of the optical disector (West and Gundersen, 1990; Madeira et al., 1995; Leal et al., 
1998; Paula-Barbosa et al., 2001), as described above, but by using a step size of 350 µm 
along the x and y axes. These procedures were implemented with the C.A.S.T.-Grid system 
software, which allows the estimation of the mean somatic volume using a spatial line grid. 
Measurements of intersections between the cell membrane and the spatial line grid were 
performed using a two-grid line and two focal planes per each cell, at magnification of 
2000x. The mean CE of the estimates was 0.07. 
 
Statistical analysis 
The precision of individual estimates of neuron numbers was evaluated as the CE, as 
described by Gundersen et al. (1999). The precision of individual estimates of mean somatic 
volumes was calculated by applying the equation: CE2 = CV2/n (Gundersen and Jensen, 
1987), in which CV denotes the intraindividual coefficient of variation (CV = Standard 
deviation/mean) and n is the number of observations in one animal. The mean CE was 
calculated from estimates for an individual, as described by West et al. (1991). Differences 
across groups were assessed by one-way analysis of variance (ANOVA). Whenever 
significant effects were detected by ANOVA, pair-wise comparisons were done by using the 
Tukey’s HSD test. Comparisons between adult and old CET rats were done using the 









No differences in the location and packing density of NPY-ir neurons were noticed among 
the groups studied. 
 
Total number of NPY-immunoreactive neurons 
The estimates of the total number of NAc NPY-ir neurons are shown in Figure 3. ANOVA 
revealed that the variations in the NPY expression were dependent on the effect of treatment 
(F(3,16) = 5,301; P = 0.011). The statistical analysis revealed that CET and W+NGF produced 
a significant increase in the total number of NPY-ir neurons relatively to control (Tukey´s 
post hoc test: P = 0.017 and P = 0.038, respectively) and W (Tukey´s post hoc test: P = 0.018 
and P = 0.042, respectively) rats. However, no significant differences were detected in the 
total number of NAc NPY-ir neurons between control and W rats. Additionally, in old CET 
rats the total number of NPY-ir neurons was reduced by 48% relative to adult CET rats 
(Student`s t-test, P < 0,0001). 
 
Somatic size of NPY-immunoreactive neurons 
Statistical analysis (ANOVA) revealed a significant effect of treatment on the mean somatic 
volume of neurons immunostained for NPY (F(3,16) = 2.015; P = 0,0452) and the Tukey´s post 
hoc test revealed no significative differences between groups. Likewise, Student`s t-test also 
revealed no differences (P = 0,056) in the somatic volume of NPY-ir neurons between adult 








The present study reveals an age-dependent effect of ethanol on the total number of NPY-ir 
neurons in the NAc. Indeed, the results of the present study show that in adult CET rats the 
number of NPY-ir neurons is higher than in controls and old CET rats. This study also 
indicates that W restores the number of NPY-ir neurons to control numbers and that NGF 
administration to W rats leads to an increase in the expression of NPY in the NAc.  
Additionally, it is also shown that there are no differences in the somatic size of NPY-
ir neurons among all groups analyzed. The effect of CET and W on somatic volumes seems 
to be region-specific. In fact, no CET- or W-induced changes have been noticed in the 
hypothalamic parvicellular neurons (Silva et al., 2002; Paula-Barbosa et al., 2003), as 
opposed to the hypothalamic magnocellular neurons where CET increases and W restores 
neuronal volumes (Madeira et al., 1993) and to the basal forebrain cholinergic neurons, where 
CET induces a reduction in the somatic volume that is further aggravated by W (Cadete-Leite 
et al., 2003). The absence of variation in neuronal size of W rats treated with NGF is 
interesting in light of data showing that administration of NGF to W rats leads to neuronal 
hypertrophy in the suprachiasmatic nucleus and basal forebrain (Paula-Barbosa et al., 2001; 
Cadete-Leite et al., 2003). Similar to this work, it was previously reported that NGF treatment 
of old rats does not induce somatic size changes in NPY-ir neurons of the NAc (unpublished 
results).  
Previous investigations have shown that CET, as well as W, alter central NPY 
expression. CET and W have been found to reduce NPY signaling in the cortex, amygdala 
and hypothalamus (Roy and Pandey, 2002). On the contrary, it has also been demonstrated 
that CET (Clark et al., 1998) and W (Bison and Crews, 2003) induce a significant increase in 




investigations were restricted to biochemical data and qualitative observations of 
immunostained material. In our study, an increase was found in the total number of NPY-ir 
neurons in adult CET rats. It has been suggested that increased NPY activity in response to 
ethanol may serve as a protective mechanism to further limit ethanol intake (Thiele et al., 
2000). This occurrence might be explained by the long-term increase in cholinergic activity 
parallel to a similar raise in the dopaminergic neurotransmission in the NAc due to CET 
(Nestby et al., 1997; Nestby et al., 1999). Accumulated evidence suggests a crucial role for 
central dopaminergic and dopamine (DA)-sensitive neurons in mediating natural as well as 
drug-rewarded behavior (Nestby et al., 1997). Expression of NPY in the rat NAc is under the 
influence of the dopaminergic mesencephalic pathway, through D1 postsynaptic receptors 
(Lindefors et al., 1990; Salin et al., 1990; Midgley et al., 1994). The mechanism underlying 
ethanol activation of this dopaminergic system is not clearly understood. However, it has 
been suggested that ethanol elevates DA levels by either disinhibiting GABAergic (gamma-
aminobutyric acid) interneurons due to direct activation of GABAA receptors, thus removing 
tonic inhibitory influences, or by influencing afferents, that will modulate the firing 
properties of the ventral tegmental area (VTA) pathways (Grobin et al., 1998; Floresco et al., 
2003). So, the cholinergic excitatory input to the dopaminergic neurons in the VTA might be 
an important part of this neuronal circuits (Larsson and Engel, 2004). Mesencephalic 
dopaminergic neurons receive cholinergic inputs from the pedunculopontine and the 
laterodorsal tegmental nuclei (Woolf, 1991), and the mesencephalic pathway is the main 
known dopaminergic afferent system of the NAc (Chen et al., 2009). It has been shown that 
cholinergic agonists administered into the VTA increase extracellular DA levels in the NAc 
(Westerink et al., 1996). Subsequently, it was demonstrated that ethanol increases 
extracellular acetylcholine (ACh) levels in the VTA, and that this increase leads to a raise in 




(Larsson et al., 2005; Löf et al., 2007). However, other explanations might exist since the 
regulation of NPY levels in the NAc is believed to present a high level of complexity.  
As mentioned before, this study revealed that W restored the total number of NPY-ir 
neurons to control values. This was an interesting finding in view of the existence of studies 
reporting an increase in the NPY-ir content of the hippocampal formation of W rats, being 
hypothesized that it would exert protective effects against seizure activity (Bison and Crews, 
2003).  
Concerning the increased NPY expression in W+NGF rats, there is evidence from in 
vivo studies that many developing neurons express NPY transiently early during development 
(Wahle et al., 2000; Wirth et al., 2005). Thus, it is possible that in adult rats these neurons 
might be capable of expressing NPY when exposed to higher than normal steady-state levels 
of neurotrophins (Wirth et al., 2005). Indeed, in the visual cortex and geniculate nucleus, it 
was demonstrated that increased levels of NGF are associated with an up-regulation of cells 
immunoreactive for NPY (Aloe et al., 2001). A possible explanation for this finding is the 
activating effect of this neurotrophin on the cholinergic interneurons of the NAc, which in 
turn modulate NPY expression in this nucleus. Cholinergic interneurons are the only known 
direct source of ACh in the rat NAc (Ligorio et al., 2009). There is a growing body of 
evidence showing that NGF increases the choline acetyltransferase content and the cell body 
size of cholinergic interneurons of the neostriatum and NAc (Fischer et al., 1988; Hagg et al., 
1989), and regulates the phenotype of NPY-ir neurons. (Barnea et al., 1996; Cardoso et al., 
2006). In the few studies that have analysed the distribution of NGF receptors in the NAc, it 
was demonstrated that almost all TrkA-immunoreactive neurons co-express choline 
acetyltransferase (Sobreviela et al., 1994). Furthermore, it has been shown that NAc contains 
no immunoreactive cells for p75 neurotrophin receptor (Barrett et al., 2005). Since 




respectively (Kawaguchi et al., 1995, Pickel et al., 1998), it is not plausible that there would 
be co-expression of ACh and NPY in the same neuron. Thus, our results might derive either 
from a direct role of ACh in the control of NPYergic neurons (Wettstein et al., 1995, Cardoso 
et al., 2006) or from the cholinergic control of DA release in the NAc (Del Arco et al., 2008).  
In this study, we found a significant decrease in the number of NPY-ir neurons in old 
CET rats when compared to adult CET rats. A previous study has shown that aging leads to 
an approximately 18% decrease in the levels of NPY in the NAc (unpublished results). Thus, 
the finding in the present study of 48% reduction in the number NPY-ir neurons shows that 
there is an age-dependent effect of CET on the total number of NPY-ir neurons in the NAc. 
One possible explanation is that CET leads directly to death of this neuronal population in 
aged rats. However, this is not likely because in an earlier study (unpublished results) it was 
shown that NGF is fully capable of restoring the age-associated changes in the chemical 
phenotype of these NAc neurons. However, we cannot exclude this possibility because the 
total number of NAc neurons was not estimated in the present work. In addition, a previous 
study demonstrated a statistically significant neuronal loss in the locus ceruleus neurons of 
old CET rats, as opposed to what was observed in adult CET rats (Jaatinen et al., 2003). 
Another possibility is that the ethanol-induced DA release in the NAc is reduced in aged rats 
compared with younger animals, though the basal extracellular DA levels is increased in 





This study might help to explain the cryptic role of NPY in alcohol intake, alcohol 




consumption was first shown in a study where transgenic mice with over-expression of NPY 
consumed less alcohol (Thiele et al., 1998). It was proposed that the up-regulation of NPY 
expression may contribute to the successful behavioral adaptation to stress (Thorsell, 2008). 
The NPY system may well be one of the most interesting target systems for the development 
of treatments for alcohol dependence as well as mood disorders, such as depression and 
anxiety syndromes (Thiele et al., 2002). Alcoholism is often under-diagnosed and untreated 
in family practice. Alcohol dementia causes serious cognitive problems in many alcoholics 
and up to 19% of patients diagnosed with dementia have a history of prolonged alcohol abuse 
(Zuccala et al., 2001). Additionally, alcohol abuse in older adults is common and the 
problems associated with it are often mistaken for other conditions related with the aging 
process, leading to misdiagnosis and undertreatment of alcohol abuse and alcoholism in this 
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Fig. 1. Photomicrographs of adjacent coronal sections at mid-NAc levels of an adult rat, 
stained with Cresyl violet (A) and immunostained for NPY (B). ac, anterior commissure. 
CPu, caudate putamen. lv, lateral ventricle. NAc, nucleus accumbens. Scale bars = 125 µm. 
 
Fig. 2. Photomicrograph of a NAc NPY-ir neuron to illustrate the criteria used for sampling 
neurons for quantitative estimations. Scale bar = 5 µm.  
 
Fig. 3. Graphic representation of the total number of NPY-ir neurons in the NAc of Control, 
Adult+CET, Withdrawal, Withdrawal+NGF and Old+CET rats. Columns represent means 
and vertical bars 1 SD. The number of NPY-ir neurons is significantly increased in 
Adult+CET relative to Control and Withdrawal rats. In Withdrawal+NGF rats, the total 
number of NPY-ir neurons is significantly augmented relative to the Control and Withdrawal 
groups. The number of NPY-ir neurons is significantly reduced in Old+CET rats relative to 
Adult+CET animals. Tukey's post hoc tests: * P < 0.05, compared with Control and 
Withdrawal rats; ** P < 0.05, compared with Control and Withdrawal rats; Student`s t-test 
*** P < 0.05, compared with Adult+CET animals.  
 
Fig. 4. Graphic representation of the estimates of mean somatic volumes of NAc NPY-ir 
neurons obtained from Control, Adult+CET, Withdrawal, Withdrawal+NGF and Old+CET 
rats. Columns r epresent means and vertical bars 1 SD. The somatic size of NPY neurons is 
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This should provide the scientific rationale for the research that is reported. No heading "Introduction" 
should be used, and no results should be presented. 
 
Experimental procedures  
 
Procedures used in the research should be described in sufficient detail to permit the replication of the 
work by others. Previously published procedures should be referenced and briefly summarized. The 
source of all materials, including animals and human tissue, must be provided. The location of each 
supplier should be detailed on first use in the text. Authors must clearly describe all manipulations made 





This section presents findings without discussion of their significance. Subsections should be used in 




This section presents the authors' interpretations of their findings and an assessment of their 
significance in relation to previous work. Avoid repetition of material presented in the Results section. 




The main conclusions of the study may be presented in a short Conclusions section, which may stand 
alone or form a subsection of the Discussion section. 
 
Glossary  
Please supply, as a separate list, the definitions of field-specific terms used in your article. 
 
Appendices  
If there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in 
 
 
appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent appendix, 
Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; Fig. A.1, etc. 
 
Essential title page information  
 
• Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid 
abbreviations and formulae where possible. 
• Author names and affiliations. Where the family name may be ambiguous (e.g., a double name), 
please indicate this clearly. Present the authors' affiliation addresses (where the actual work was done) 
below the names. Indicate all affiliations with a lower-case superscript letter immediately after the 
author's name and in front of the appropriate address. Provide the full postal address of each affiliation, 
including the country name, and, if available, the e-mail address of each author. 
• Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing 
and publication, also post-publication. Ensure that telephone and fax numbers (with country and 
area code) are provided in addition to the e-mail address and the complete postal address. 
Contact details must be kept up to date by the corresponding author.  
• Present/permanent address. If an author has moved since the work described in the article was 
done, or was visiting at the time, a "Present address" (or "Permanent address") may be indicated as a 
footnote to that author's name. The address at which the author actually did the work must be retained 




A concise and factual abstract is required. The abstract should state briefly (in less than 300 words) the 
purpose of the research and the principal results obtained. The abstract should conclude with a final 
statement summarizing the major conclusions in such a way that the implications of the work to the field 
would be clear to a general neuroscience reader. An abstract is often presented separately from the 
article, so it must be able to stand alone. For this reason, References should be avoided, but if essential, 
then cite the author(s) and year(s). Also, non-standard or uncommon abbreviations should be avoided, 
but if essential they must be defined at their first mention in the abstract itself. 
 
Graphical abstract  
 
A Graphical abstract is optional and should summarize the contents of the article in a concise, pictorial 
form designed to capture the attention of a wide readership online. Authors must provide images that 
clearly represent the work described in the article. Graphical abstracts should be submitted as a 
separate file in the online submission system. Image size: Please provide an image with a minimum of 
531 × 1328 pixels (h × w) or proportionally more. Preferred file types: TIFF, EPS, PDF or MS Office files. 




Highlights are mandatory for this journal. They consist of a short collection of bullet points that convey 
the core findings of the article and should be submitted in a separate file in the online submission 
system. Please use 'Highlights' in the file name and include 3 to 5 bullet points (maximum 85 characters 




Immediately after the abstract, provide a maximum of 6 keywords, using American spelling and avoiding 
general and plural terms and multiple concepts (avoid, for example, "and", "of"). Be sparing with 
abbreviations: only abbreviations firmly established in the field may be eligible. These keywords will be 




The excessive use of abbreviations in the text is strongly discouraged. In order to aid communication 
between scientists of different disciplines, authors should only use abbreviations sparingly and should 
always define the abbreviation when first used in the text by placing it in parentheses after the full term, 
e.g. acetylcholinesterase (AChE). The abbreviations should then be used consistently thereafter and 
appear at least twice in the text. A comprehensive list of the abbreviations used should be put on a 




Collate acknowledgements in a separate section at the end of the article before the references and do 
not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those 
 
 
individuals who provided help during the research (e.g., providing language help, writing assistance or 
proof reading the article, etc.). It is the corresponding author's responsibility to insure that individuals 
who are acknowledged for assistance or for providing comments on the manuscript are agreeable to 




Follow internationally accepted rules and conventions: use the international system of units (SI). If other 
units are mentioned, please give their equivalent in SI. 
 
Nomenclature and units  
 
Follow internationally accepted rules and conventions: use the international system of units (SI). If other 
quantities are mentioned, give their equivalent in SI. You are urged to consult IUGS: Nomenclature for 
geological time scales/rock names: http://www.iugs.org/for further information.  
 
Symbols for physical units should be restricted to the Systems Internationale (S.I.) Units. Drug names 
should be the official or approved names; trade names or common names may be given in brackets 
where the drug is first mentioned. The manufacturer's name must be given. The doses of the drugs 
should be given as unit weight/unit body weight, e.g. mmol/kg or mg/kg. 
 
Database linking and Accession numbers  
 
Elsevier aims at connecting online articles with external databases which are useful in their respective 
research communities. If your article contains relevant unique identifiers or accession numbers 
(bioinformatics) linking to information on entities (genes, proteins, diseases, etc.) or structures 
deposited in public databases, then please indicate those entities according to the standard explained 
below. 
Authors should explicitly mention the database abbreviation (as mentioned below) together with the 
actual database number, bearing in mind that an error in a letter or number can result in a dead link in 
the online version of the article. 
Please use the following format: Database ID: xxxx  
Links can be provided in your online article to the following databases (examples of citations are given in 
parentheses): 
• GenBank: Genetic sequence database at the National Center for Biotechnical Information (NCBI) 
(GenBank ID: BA123456) 
• PDB: Worldwide Protein Data Bank (PDB ID: 1TUP) 
• CCDC: Cambridge Crystallographic Data Centre (CCDC ID: AI631510) 
• TAIR: The Arabidopsis Information Resource database (TAIR ID: AT1G01020) 
• NCT: ClinicalTrials.gov (NCT ID: NCT00222573) 
• OMIM: Online Mendelian Inheritance in Man (OMIM ID: 601240) 
• MINT: Molecular INTeractions database (MINT ID: 6166710) 
• MI: EMBL-EBI IntAct database for Molecular Interactions (MI ID: 0218) 




Electronic artwork  
• Number the illustrations according to their sequence in the text.  
• Use a logical naming convention for your artwork files.  
• Provide captions to illustrations separately.  
• Produce images near to the desired size of the printed version.  
• Submit each figure as a separate file.  
 
A detailed guide on electronic artwork is available on our website:  
http://www.elsevier.com/artworkinstructions  
You are urged to visit this site; some excerpts from the detailed information are given here.  
Formats  
Regardless of the application used, when your electronic artwork is finalised, please "save as" or convert 
the images to one of the following formats (note the resolution requirements for line drawings, 
halftones, and line/halftone combinations given below):  
EPS: Vector drawings. Embed the font or save the text as "graphics".  
TIFF: color or grayscale photographs (halftones): always use a minimum of 300 dpi.  
TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.  
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required.  
DOC, XLS or PPT: If your electronic artwork is created in any of these Microsoft Office applications 
please supply "as is".  
 
 
• Do not supply embedded graphics in your wordprocessor (spreadsheet, presentation) document;  
• Do not supply files that are optimised for screen use (like GIF, BMP, PICT, WPG); the resolution is too 
low;  
• Do not supply files that are too low in resolution;  
• Do not submit graphics that are disproportionately large for the content. 
 
Color artwork  
Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with 
the correct resolution. If, together with your accepted article, you submit usable color figures then 
Elsevier will ensure, at no additional charge, that these figures will appear in color on the Web (e.g., 
ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in color in 
the printed version. For color reproduction in print, you will receive information regarding the 
costs from Elsevier after receipt of your accepted article. Please indicate your preference for color 
in print or on the Web only. For further information on the preparation of electronic artwork, please see 
http://www.elsevier.com/artworkinstructions.  
Please note: Because of technical complications which can arise by converting color figures to "gray 
scale" (for the printed version should you not opt for color in print) please submit in addition usable 
black and white versions of all the color illustrations. 
 
Cover art  
Illustrations to be considered for the cover should be related to the authors' submittedC article and be 
representative of their data, but need not necessarily be as they appear in the manuscript. Cover art 
should be formatted to occupy the entire 8.5 X 11 inch cover and should be submitted in digital format 
(TIFF, Photoshop, JPEG or Powerpoint) with a resolution of at least 300 dpi. Please also include a 
descriptive text with your cover art submission. The files should be uploaded to a specified FTP site. 
Please contact the Editorial Office at neuroscience@journal-office.com for instructions. For authors who 
wish to postal mail a CD with the cover art, please send it to: Neuroscience Editorial Office, 525 B 
Street, Suite 1700, San Diego, CA 92101, U.S.A. Please ensure that the manuscript reference number is 
included on all materials. 
 
Figure captions  
Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A 
caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep 
text in the illustrations themselves to a minimum but explain all symbols and abbreviations used. 
 
Text graphics  
Text graphics may be embedded in the text at the appropriate position. Further, high-resolution graphics 





Number tables consecutively in accordance with their appearance in the text. Place footnotes to tables 
below the table body and indicate them with superscript lowercase letters. Avoid vertical rules. Be 
sparing in the use of tables and ensure that the data presented in tables do not duplicate results 




The reference list should be included at the end of the main text. A paper which has been accepted for 
publication but which has not appeared may be cited in the reference list with the abbreviated name of 
the journal followed by the words "in press". See Reference Style below. 
 
Citation in text  
Please ensure that every reference cited in the text is also present in the reference list (and vice versa). 
Any references cited in the abstract must be given in full. Unpublished results and personal 
communications are not recommended in the reference list, but may be mentioned in the text. If these 
references are included in the reference list they should follow the standard reference style of the 
journal and should include a substitution of the publication date with either "Unpublished results" or 
"Personal communication" Citation of a reference as "in press" implies that the item has been accepted 
for publication. 
 
Personal Communications may be used only when written authorization from the communicator is 
submitted with the original manuscript; they may be mentioned only in the text and in the following 
form: (G.H. Orwell, Department of Psychiatry, University of Washington, personal communication). 
Unpublished or submitted experiments by one of the authors may be mentioned only in the text, not in 
the References. Initials, as well as surnames, must be given for authors whose unpublished experiments 
 
 
are quoted: (M.L. King, unpublished observations). 
 
Web references  
As a minimum, the full URL should be given and the date when the reference was last accessed. Any 
further information, if known (DOI, author names, dates, reference to a source publication, etc.), should 
also be given. Web references can be listed separately (e.g., after the reference list) under a different 
heading if desired, or can be included in the reference list. 
 
Reference to arXiv  
As with unpublished results and personal communications, references to arXiv documents are not 
recommended in the reference list. Please make every effort to obtain the full reference of the published 
version of an arXiv document. If a reference to an arXiv document must be included in the references 
list it should follow the standard reference style of the journal and should include a substitution of the 
volume and page numbers with 'arXiv:YYMM.NNNN' or 'arXiv:arch-ive/YYMMNNN' for papers submitted 
to arXiv before April 2007. 
 
References in a special issue  
Please ensure that the words 'this issue' are added to any references in the list (and any citations in the 
text) to other articles in the same Special Issue. 
 
Reference style  
 
In the text, references should be quoted as the name of the first author and year in chronological order. 
Multiple authors are indicated by "et al.", except when there are only two authors, in which case both 
names are written. For example, The pattern of the pathology instead represents a synaptically 
connected network of neurons (Braak and Braak, 1991; Morris, 1997). This hypothesis was recently 
proposed by Nagy et al. (1997). 
 
The reference list should be on a separate page at the end of the manuscript, in alphabetical order 
and arranged as follows: authors' names and initials, year, title of the article, abbreviated title of the 
journal, volume, first and last page numbers. Journal titles should be abbreviated according to the rules 
adopted in the fourth edition of the World List of Scientific Periodicals (Butterworths, 1965). Note that 
first and last pages are given in full. For example, Nagy ZA, Esiri MM, Cato A-M, Smith AD (1997), 
Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropath 94:6-15. 
 
References to books should include the authors' names and initials, year, title of book, volume, 
publisher, place of publication and page numbers. Where relevant, the title of a paper within a book, and 
the editor's name(s) should be given. For example, Morris JH (1997) Alzheimer's disease. In: The 
neuropathology of dementia, vol. 2 (Esiri MM, Morris JH, eds), pp 70-121. Cambridge: Cambridge 
University Press. 
 
Journal abbreviations source  
Journal names should be abbreviated according to  
Index Medicus journal abbreviations: http://www.nlm.nih.gov/tsd/serials/lji.html;  
List of title word abbreviations: http://www.issn.org/2-22661-LTWA-online.php;  
CAS (Chemical Abstracts Service): http://www.cas.org/sent.html. 
 
Video data  
 
Elsevier accepts video material and animation sequences to support and enhance your scientific 
research. Authors who have video or animation files that they wish to submit with their article are 
strongly encouraged to include these within the body of the article. This can be done in the same way as 
a figure or table by referring to the video or animation content and noting in the body text where it 
should be placed. All submitted files should be properly labeled so that they directly relate to the video 
file's content. In order to ensure that your video or animation material is directly usable, please provide 
the files in one of our recommended file formats with a preferred maximum size of 50 MB. Video and 
animation files supplied will be published online in the electronic version of your article in Elsevier Web 
products, including ScienceDirect: http://www.sciencedirect.com. Please supply 'stills' with your files: 
you can choose any frame from the video or animation or make a separate image. These will be used 
instead of standard icons and will personalize the link to your video data. For more detailed instructions 
please visit our video instruction pages at http://www.elsevier.com/artworkinstructions. Note: since 
video and animation cannot be embedded in the print version of the journal, please provide text for both 
the electronic and the print version for the portions of the article that refer to this content. 
 
Supplementary data  
 
Neuroscience accepts electronic supplementary material to support and enhance your scientific research. 
 
 
Supplementary files offer the author additional possibilities to publish supporting applications, sound 
clips, videos, and other formats that cannot yet be embedded in our standard PDF files Elsevier accepts 
electronic supplementary material to support and enhance your scientific research. Supplementary files 
supplied will be published online alongside the electronic version of your article in Elsevier Web products, 
including ScienceDirect: www.sciencedirect.com. In order to ensure that your submitted material is 
directly usable, please provide the data in one of our recommended file formats. Authors should submit 
the material in electronic format together with the article and supply a concise and descriptive caption 
for each file. For more detailed instructions please visit our artwork instruction pages at 
www.elsevier.com/artworkinstructions.  
 
For Neuroscience, authors are allowed to post supplementary material for review, but for publication 
supplementary material will be restricted to formats that cannot be published in the standard form of a 
PDF, such as movies. 
 
Submission checklist  
It is hoped that this list will be useful during the final checking of an article prior to sending it to the 
journal's Editor for review. Please consult this Guide for Authors for further details of any item.  
Ensure that the following items are present:  
One Author designated as corresponding Author:  
• E-mail address  
• Full postal address  
• Telephone and fax numbers  
All necessary files have been uploaded  
• Keywords  
• All figure captions  
• All tables (including title, description, footnotes)  
Further considerations  
• Manuscript has been "spellchecked" and "grammar-checked"  
• References are in the correct format for this journal  
• All references mentioned in the Reference list are cited in the text, and vice versa  
• Cover letter includes your agreement to the ethical standards: "I have read and have abided by 
the statement of ethical standards for manuscripts submitted to Neuroscience," as well as the 
other statement that all authors have approved the final article.  
• Permission has been obtained for use of copyrighted material from other sources (including the Web)  
• Color figures are clearly marked as being intended for color reproduction on the Web (free of charge) 
and in print or to be reproduced in color on the Web (free of charge) and in black-and-white in print  
• If only color on the Web is required, black and white versions of the figures are also supplied for 
printing purposes  
For any further information please visit our customer support site at http://epsupport.elsevier.com. 
 




Use of the Digital Object Identifier  
 
The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI 
consists of a unique alpha-numeric character string which is assigned to a document by the publisher 
upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium 
for citing a document, particularly 'Articles in press' because they have not yet received their full 
bibliographic information. The correct format for citing a DOI is shown as follows (example taken from a 
document in the journal Physics Letters B):  
doi:10.1016/j.physletb.2010.09.059  





One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do not 
have an e-mail address then paper proofs will be sent by post) or, a link will be provided in the e-mail so 
that authors can download the files themselves. Elsevier now provides authors with PDF proofs which 
can be annotated; for this you will need to download Adobe Reader version 7 (or higher) available free 
from http://get.adobe.com/reader. Instructions on how to annotate PDF files will accompany the 




If you do not wish to use the PDF annotations function, you may list the corrections (including replies to 
the Query Form) and return them to Elsevier in an e-mail. Please list your corrections quoting line 
number. If, for any reason, this is not possible, then mark the corrections and any other comments 
(including replies to the Query Form) on a printout of your proof and return by fax, or scan the pages 
and e-mail, or by post. Please use this proof only for checking the typesetting, editing, completeness 
and correctness of the text, tables and figures. Significant changes to the article as accepted for 
publication will only be considered at this stage with permission from the Editor. We will do everything 
possible to get your article published quickly and accurately – please let us have all your corrections 
within 48 hours. It is important to ensure that all corrections are sent back to us in one communication: 
please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. 
Proofreading is solely your responsibility. Note that Elsevier may proceed with the publication of your 




The corresponding author, at no cost, will be provided with a PDF file of the article via e-mail or, 
alternatively, 25 free paper offprints. If the corresponding author opts for paper offprints, this 
preference must be indicated via the offprint order form which is sent once the article is accepted for 
publication. Additional paper offprints can also be ordered via this form for an extra charge. The PDF file 
is a watermarked version of the published article and includes a cover sheet with the journal cover 
image and a disclaimer outlining the terms and conditions of use. 
 




For inquiries relating to the submission of articles (including electronic submission) please visit this 
journal's homepage. Contact details for questions arising after acceptance of an article, especially those 
relating to proofs, will be provided by the publisher. You can track accepted articles at 
http://www.elsevier.com/trackarticle. You can also check our Author FAQs (  
http://www.elsevier.com/authorFAQ) and/or contact Customer Support via 
http://support.elsevier.com 
  
